Study represents a significant advancement in Grove’s Bionic Biologics™ platform –CHICAGO--(BUSINESS WIRE)--Grove Biopharma, ...
U.S. Investigational New Drug (IND) applications for radiotheranostic pair PentixaFor and PentixaTher became active following completion of the FDA 30-day review period.Proposed phase I/II trial ...
Revenue Cycle Management Leader Expands AI Adoption, Strengthens Industry Advocacy, and Builds for Next Phase of ...
Medincell (Euronext Paris: MEDCL), a commercial- and clinical-stage biopharmaceutical licensing company developing ...
GOTHENBURG, SE / ACCESS Newswire / February 25, 2026 / IRLAB Therapeutics AB (STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for Parkinson's disease, today announced ...
MetLife, Inc. (NYSE: MET) today announced that Dan Glaser and Michelle Seitz were elected to its Board of Directors (the ...
Meanwhile, the Asia-Pacific region is anticipated to register the fastest growth rate. This trend is attributed to a rapidly ...
Aeris and Verizon Business Simplify Global IoT Expansion with Unified Connectivity and Orchestration
Services enable multinational enterprises to localize U.S. devices in weeks instead of months using Verizon Business’ IoT ...
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, ...
OmniAb, Inc. (NASDAQ: OABI) today announced that management will participate at the Leerink Global Healthcare Conference ...
Pharmaceutical sales in the UK are undergoing a gradual but meaningful shift in who represents medicines to healthcare ...
Alkermes is a fully integrated biopharmaceutical company headquartered in Dublin, Ireland, with R&D and manufacturing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results